Michaeli, Christoph T. Prof. Dr. med.Universität HeidelbergHeidelberg
Refine publication list
Year of publication
Type of Publication
Language
Co-author (Univ. of Heidelberg)
- Torre, Carolina de la (1)
- Winter, Hauke (1)
- Imbusch, Charles (1)
- Janning, Melanie (1)
- An, Liying (1)
- Loges, Sonja (1)
- Schreiner, Yannick (1)
- Beumer, Niklas (1)
- Faust, Sara (1)
- Krämer, Bernhard (1)
Co-author (external)
- Dannehl, Dominik (1)
- Frost, Nikolaj (1)
- Roeper, Julia (1)
- Szuszies, Chrisoph J. (1)
- Sommer, Linna (1)
- Miracolo, Aurelio (1)
- Mills, Mackenzie (1)
- Zhang, Wenjia (1)
- Stoycheva, Sophia (1)
- Marcus, Simon Mashudu (1)
- Yagmur, Hasan (1)
- Trapani, Dario (1)
Recent publications in heiBIB 
(In total there are 29 publications catalogued)
- Michaeli, Daniel: Value-based indication-specific pricing and weighted-average pricing : estimated price and cost savings for cancer drugs / Daniel Tobias Michaeli, Thomas Michaeli, April 2025. - 13 S.
In: PharmacoEconomics, ISSN 1179-2027. 43(2025), 4 vom: Apr., Seite 415-427
DOI: 10.1007/s40273-024-01448-x
- Michaeli, Daniel: The healthcare workforce shortage of nurses and physicians : practice, theory, evidence, and ways forward / Daniel Tobias Michaeli, Julia Caroline Michaeli, Sebastian Albers, Thomas Michaeli. -
Los Angeles: Sage, 2024. - 1 Online-Ressource (12 Seiten) : Diagramme
DOI: 10.11588/heidok.00036055
- Michaeli, Christoph T.: Krebsprävention, Krebstherapie und Cancer Survivorship: Ökonomie, Implikationen für Patienten, Leistungserbringer und Leistungsträger im Gesundheitswesen / vorgelegt von Dr. med. Christoph Thomas Michaeli. -
Heidelberg, 2024. - 125 Blätter : Diagramme
- Michaeli, Julia: Breast cancer drugs: FDA approval, development time, efficacy, clinical benefits, innovation, trials, endpoints, quality of life, value, and price / Julia Caroline Michaeli, Thomas Michaeli, Dario Trapani, Sebastian Albers, Dominik Dannehl, Rachel W… , November 2024. - 12 S.
In: Breast cancer, ISSN 1880-4233. 31(2024), 6 vom: Nov., Seite 1144-1155
DOI: 10.1007/s12282-024-01634-x
- Michaeli, Daniel: Clinical trial design and treatment effects : a meta-analysis of randomised controlled and single-arm trials supporting 437 FDA approvals of cancer drugs and indications / Daniel Tobias Michaeli, Thomas Michaeli, Sebastian Albers, Julia Caroline Michaeli, September 20, 2024. - 9 S.
In: BMJ evidence-based medicine, ISSN 2515-4478. 29(2024), 5 vom: Sept., Seite 333-341
DOI: 10.1136/bmjebm-2023-112544
- Michaeli, Daniel: Breakthrough therapy cancer drugs and indications with FDA approval : development time, innovation, trials, clinical benefit, epidemiology, and price / Daniel Tobias Michaeli, MSc, MSc, and Thomas Michaeli, MD, MSc, MSc, May 2024. - 9 S. : Illustrationen
In: Journal of the National Comprehensive Cancer Network, ISSN 1540-1413. 22(2024), 4, Seite 1-9
DOI: 10.6004/jnccn.2023.7110
- Michaeli, Christoph T.: Partial orphan cancer drugs : US food and drug administration approval, clinical benefit, trials, epidemiology, price, beneficiaries, and spending / Thomas Michaeli, Daniel Tobias Michaeli, 18 January 2024. - 9 S.
In: Value in health, ISSN 1524-4733. 27(2024), 4, Seite 449-457
DOI: 10.1016/j.jval.2024.01.002
- Michaeli, Daniel: Patient enrollment per month (accrual) in clinical trials leading to the FDA approval of new cancer drugs / Daniel Tobias Michaeli, Thomas Michaeli, Sebastian Albers, Julia Caroline Michaeli, September 2024. - 13 S. : Illustrationen
In: Targeted oncology, ISSN 1776-260X. 19(2024), 5 vom: Sept., Seite 797-809
DOI: 10.1007/s11523-024-01081-w
- Michaeli, Daniel: Special FDA designations for drug development : orphan, fast track, accelerated approval, priority review, and breakthrough therapy / Daniel Tobias Michaeli, Thomas Michaeli, Sebastian Albers, Tobias Boch, Julia Caroline Michaeli, 2024. - 19 S. : Illustrationen
In: The European journal of health economics, ISSN 1618-7601. 25(2024), 6 vom: Aug., Seite 979-997
DOI: 10.1007/s10198-023-01639-x
- Michaeli, Daniel: Clinical benefit, development, innovation, trials, epidemiology, and price for cancer drugs and indications with multiple special FDA designations / Daniel Tobias Michaeli, MSc, MSc, BSc, Thomas Michaeli, MD, MSc, MSc, BSc, Sebastian Albers , MD, Ju… , February 2024. - 14 S.
In: Journal of the National Cancer Institute, ISSN 1460-2105. 116(2024), 2 vom: Feb., Seite 216-229
DOI: 10.1093/jnci/djad212
